These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32627966)

  • 1. Altered Properties of Endothelial Cells and Mesenchymal Stem Cells Underlying the Development of Scleroderma-like Vasculopathy in KLF5
    Nakamura K; Taniguchi T; Hirabayashi M; Yamashita T; Saigusa R; Miura S; Takahashi T; Toyama T; Ichimura Y; Yoshizaki A; Trojanowska M; Fujiu K; Nagai R; Sato S; Asano Y
    Arthritis Rheumatol; 2020 Dec; 72(12):2136-2146. PubMed ID: 32627966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double heterozygous mice for Klf5 and Fli1 genes: a new animal model of systemic sclerosis recapitulating its three cardinal pathological features.
    Asano Y
    Med Mol Morphol; 2015 Sep; 48(3):123-8. PubMed ID: 25986681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.
    Noda S; Asano Y; Nishimura S; Taniguchi T; Fujiu K; Manabe I; Nakamura K; Yamashita T; Saigusa R; Akamata K; Takahashi T; Ichimura Y; Toyama T; Tsuruta D; Trojanowska M; Nagai R; Sato S
    Nat Commun; 2014 Dec; 5():5797. PubMed ID: 25504335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis.
    Taniguchi T; Asano Y; Nakamura K; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S
    J Rheumatol; 2017 Aug; 44(8):1198-1205. PubMed ID: 28507181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding ability.
    Akamata K; Asano Y; Yamashita T; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Trojanowska M; Sato S
    Arthritis Rheumatol; 2015 May; 67(5):1335-44. PubMed ID: 25707716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Uuifying hypothesis for the pathogenesis of systemic sclerosis based on the deficiency of transcription factor Fli1 - the development of a new animal model of systemic sclerosis -].
    Asano Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):475-87. PubMed ID: 25748132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in animal models of systemic sclerosis.
    Asano Y
    J Dermatol; 2016 Jan; 43(1):19-28. PubMed ID: 26782003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy.
    Asano Y; Stawski L; Hant F; Highland K; Silver R; Szalai G; Watson DK; Trojanowska M
    Am J Pathol; 2010 Apr; 176(4):1983-98. PubMed ID: 20228226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis.
    Yamashita T; Asano Y; Saigusa R; Taniguchi T; Nakamura K; Miura S; Toyama T; Takahashi T; Ichimura Y; Hirabayashi M; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    J Dermatol Sci; 2019 Jan; 93(1):24-32. PubMed ID: 30270117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis.
    Yamaguchi Y; Okazaki Y; Seta N; Satoh T; Takahashi K; Ikezawa Z; Kuwana M
    Arthritis Res Ther; 2010; 12(6):R205. PubMed ID: 21050433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis.
    Akamata K; Asano Y; Taniguchi T; Yamashita T; Saigusa R; Nakamura K; Noda S; Aozasa N; Toyama T; Takahashi T; Ichimura Y; Sumida H; Tada Y; Sugaya M; Kadono T; Sato S
    Rheumatology (Oxford); 2015 Jul; 54(7):1308-16. PubMed ID: 25539827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
    Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice.
    Taniguchi T; Asano Y; Akamata K; Noda S; Takahashi T; Ichimura Y; Toyama T; Trojanowska M; Sato S
    Arthritis Rheumatol; 2015 Feb; 67(2):517-26. PubMed ID: 25385187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis.
    Miyagawa T; Taniguchi T; Saigusa R; Fukayama M; Takahashi T; Yamashita T; Hirabayashi M; Miura S; Nakamura K; Yoshizaki A; Sato S; Asano Y
    Rheumatology (Oxford); 2020 Aug; 59(8):2005-2015. PubMed ID: 31782787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow endothelial progenitors are defective in systemic sclerosis.
    Del Papa N; Quirici N; Soligo D; Scavullo C; Cortiana M; Borsotti C; Maglione W; Comina DP; Vitali C; Fraticelli P; Gabrielli A; Cortelezzi A; Lambertenghi-Deliliers G
    Arthritis Rheum; 2006 Aug; 54(8):2605-15. PubMed ID: 16868984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis.
    Saigusa R; Asano Y; Taniguchi T; Yamashita T; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
    Exp Dermatol; 2015 Feb; 24(2):127-32. PubMed ID: 25421497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.
    Noda S; Asano Y; Takahashi T; Akamata K; Aozasa N; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    Rheumatology (Oxford); 2013 May; 52(5):790-9. PubMed ID: 23287360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.
    Trojanowska M
    Nat Rev Rheumatol; 2010 Aug; 6(8):453-60. PubMed ID: 20585340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
    Cipriani P; Guiducci S; Miniati I; Cinelli M; Urbani S; Marrelli A; Dolo V; Pavan A; Saccardi R; Tyndall A; Giacomelli R; Cerinic MM
    Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.